This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Archived

This page has been archived on the Web.

Health product recall

Hyper FX (2014-01-14)

Starting date:
January 14, 2014
Posting date:
January 28, 2014
Type of communication:
Drug Recall
Subcategory:
Natural health products
Hazard classification:
Type II
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-37731

Recalled Products

Hyper FX

Reason

The product was removed because the amount of caffeine (665 mg/day) in the presence of synephrine exceeds the acceptable amount.

Depth of distribution

Retailers in Canada

Affected products

Hyper FX

DIN, NPN, DIN-HIM
No Market Authorization
Dosage form

Powder

Strength

Synéphrine 24 mg/day
Cafeine 665 mg/day

Lot or serial number

21454A
20584A
21434A
20454A
20614A
21424A
20123A
234940A

Companies
Recalling Firm
Empire Health Distribution
585 Fernand Poitras
Terrebonne
J6Y 1Y5
Quebec
CANADA
Marketing Authorization Holder
Not Applicable

Date modified: